Nishida, S <br/><br/>
Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow.  [electronic resource] 

 -  Bone   
 - 717-23 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>8756-3282 
<br/><br/><label>Standard No.: </label>10.1016/8756-3282(94)90322-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkaline Phosphatase--metabolism<br/>Animals<br/>Biomechanical Phenomena<br/>Bone Density--drug effects<br/>Bone Development--drug effects<br/>Bone Marrow--drug effects<br/>Bone Marrow Cells<br/>Cell Count<br/>Cell Differentiation--drug effects<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Colony-Forming Units Assay<br/>Female<br/>Femur--drug effects<br/>Humans<br/>Injections, Subcutaneous<br/>Osteoclasts--drug effects<br/>Parathyroid Hormone--administration & dosage<br/>Peptide Fragments--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Stem Cells--cytology<br/>Teriparatide<br/>Tibia--drug effects